MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
Potrebbe interessarti anche
Chi ha guadagnato
Ultime notizie crypto
WSJ: Gli investitori diffidano di un nuovo round del "Crypto Winter"
Aethir pubblica una roadmap di 12 mesi per accelerare la crescita nel business globale dell'IA Computing
Elenco di afflussi/deflussi di finanziamenti spot a 24 ore: ETH Net Outflow di 126 milioni di dollari, ZEC Net Outflow di 18,2 milioni di dollari
Bloomberg: La Fed non è mai stata così divisa sulla strategia Long Rate
Dati chiave delle transazioni: Rendimento del Tesoro USA a 10 anni sale al 4,086%
Assistenza clienti:@weikecs
Cooperazione aziendale:@weikecs
Trading quantitativo e MM:[email protected]
Servizi VIP:[email protected]